E.S.PKU Conference 2020

gregor.hammerschmidt Conferences

The ESPKU regret to announce that the Annual Conference scheduled for October 29th to November 1st, 2020 in Madrid has been deferred to 2021 due to the corona pandemic. We do not expect the impact of this pandemic to be resolved in time frame available. The ESPKU will consider possible virtual events and will provide further  information as appropriate. Consequently,  the 2021 Conference  will not take place in Georgia as initially planned. The Conferences in 2022 and 2023 (in France & the U.K) are not affected. This far-reaching decision was not easy for the ESPKU Board to take. However, after considering all options, this …

Spring Meeting & Conference 2020

gregor.hammerschmidt Announcements

As you are aware there is a global outbreak of the coronavirus. As a responsible organization we are alway monitoring the situation and basing our decisions on this. As the situation is very unstable at the moment we need to inform our delegates that the spring meeting 2020 will not be held in Madrid. We will continue to have our spring meeting for our delegates as an online meeting. More information is available on the workplace for delegates. Please rest assured that we are also closely monitoring the situation for our annual conference this fall. As of right now we …

Treatment for adult metabolic patients is insufficient

gregor.hammerschmidt Announcements

An increasing adult PKU population requires urgent action to avert a severe treatment crisis In Europe, neonatal screening for Phenylketonuria (PKU) has been introduced over a period of 50 years between 1964 (Belgium) and 2015 (Finland). Until the early 1990s, PKU was known as a paediatric disease. Thanks to timely diagnosis and efficient treatment options, patients have a normal life expectancy. However, the treatment of adults is still neglected even in those countries with the longest screening history. Healthcare systems are not adequately prepared for increasing patient numbers. More and more adult patients lack access to age-appropriate treatment in metabolic …

E.S.PKU Conference 2019

gregor.hammerschmidt Conferences

We are happy to host our conference in Izmir, Turkey for this year. Turkey hosts one of the biggest PKU communities and we have been keen to come back to Turkey for the last couple of years. Learn more about what to expect from our annual conference this year! There are still a couple of days left to book your ticket for the annual E.S.PKU conference. We also have already published the full conference program. This makes it easier for you to see what interesting topics will be presented this year besides meeting all those people from around the globe. …

European Guidelines Version 2

gregor.hammerschmidt Announcements

As with every publication it’s important to keep it up to date. This is why we are very proud that the work of the second edition of the European Guidelines is already underway. The kickoff for this project has taken place at the E.S.PKU Conference 2018 in Venice, Italy. As announced by Prof Francjan van Spronsen in the very beginning of the first European guidelines project – even when you are finished there is still a lot of work to be done. Now that those guidelines have been completed work is necessary to get them implemented in every country. This …

Addressing the high burden and significant unmet needs in Phenylketonuria (PKU)

gregor.hammerschmidt Announcements

Read this executive summary and download the full report. This Policy Roundtable, organised by the European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria (ESPKU), was hosted by MEPs Deirdre Clune (Ireland, EPP) and Nessa Childers (Ireland, S&D). Objectives to have an informed discussion on phenylketonuria (PKU) and its impact; to support understanding of the true nature of the condition; to identify the unmet needs in the area of PKU; to gather expert opinions on what can still be done to advance the interests of people living with PKU; to generate political momentum. Potential areas of action, arising from …

ESPKU calls for new born screening for every new born worldwide!

gregor.hammerschmidt Announcements

At the occasion of International #PKUDay 2018, ESPKU calls to implement and maintain newborn screening for all newborns around the world! 1) Agata Bak, Spain2) Duncan Noble-Nesbitt, United Kingdom3) Sanja Peric, Croatia4) Kate Hall (ISNS), UK 5) Laura Momme, Denmark6) Malgorzata Henek, Poland7) Paul van Berkel, The Netherlands8) Tobias S. Hagedorn, Germany

Pegvaliase (PalynzigTM) has been approved

gregor.hammerschmidt Scientific Advisory Committee

Fresh from the Press: Pegvaliase (now called PalynzigTM) has been approved by the FDA for use in adult PKU patients in the USA with phenylalanine > 600 micromol/l. Francjan J van Spronsen, Maria Gizewska, Anita MacDonald, Kirsten Ahring Why is a different treatment needed? ‘You are not lucky when you have PKU’ I explained to a colleague. He replied “Why? What you’ve always told me is that when left untreated, patients with PKU have severe developmental disability, epilepsy, and difficult behavioural issues. Now they lead an almost normal life by following a diet. This does not seem too bad a …